SCHEMBL7249394

SCHEMBL7249394

CCC(C)(C)C(=O)C(=O)N1CC[C@H]1C(=O)OCCCC1CCCCC1

nearest known ligand 0.89

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 20/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7392887 0.94 FKBP1A (1.00) FKBP1A
SCHEMBL5966109 0.83 FKBP1A (1.00) FKBP1A
SCHEMBL10031767 0.82 FKBP1A (0.79) FKBP1A
SCHEMBL7807355 0.82 FKBP1A (0.79) FKBP1A
SCHEMBL10031758 0.81 FKBP1A (0.78) FKBP1A
SCHEMBL10031803 0.81 FKBP1A (0.78) FKBP1A
SCHEMBL7814328 0.81 FKBP1A (0.78) FKBP1A
SCHEMBL7978726 0.80 FKBP1A (0.64) FKBP1A
SCHEMBL7978725 0.80 FKBP1A (0.64) FKBP1A
SCHEMBL28331561 0.79 FKBP1A (0.74) FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6544976-B1 Treating disorders characterized by neuronal damage caused by disease or trauma, such as Parkinson's disease, Alzheimer's disease, stroke, multiple sclerosis, amyotrophic lateral sclerosis, diabetic neuropathy and Bell's palsy. ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-04-08 US disclosed